In the three months to 30 September 2022, total revenue at Renishaw rose 14% to £179.9m, including a £4m currency benefit. Revenue in the company manufacturing technologies business segment saw a 13% increase to £172.8m while the analytical instruments and medical devices segment was 29% higher at £7.1m. Statutory pre-tax profit declined 2% to £38.6m and adjusted pre-tax profit was down 4% at £40m from the prior year. Renishaw stated it saw growth across all regions.
Renishaw also stated that it had made a positive start to its current financial year and that the order book remains strong.
“We have recently seen a weakening in order intake from the semiconductor and electronics sectors, and general market sentiment is becoming more cautious,” the company said. “In light of this, we are managing costs carefully and focusing on productivity. Overall, we’re confident in our strategy and the investments we’re making in people and infrastructure to deliver sustainable, long-term growth, and we look forward to the year ahead.”
For more information: www.renishaw.com